Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease model

BACKGROUND: The endocannabinoids system (ECs) mediated mainly by CB1 and CB2 receptors plays an important role in non-alcoholic fatty liver disease by regulating lipid metabolism. This study is to further investigate the expression of CB1 and CB2 in the fat accumulation liver cells and to identify p...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Dongmei, zhan, Xi, Yu, Xiaofeng, Jia, Minglei, Zhang, Ying, Yao, Jianfeng, Hu, Xiaona, Bao, Zhijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247673/
https://www.ncbi.nlm.nih.gov/pubmed/25406988
http://dx.doi.org/10.1186/1476-511X-13-173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247673/
https://www.ncbi.nlm.nih.gov/pubmed/25406988
http://dx.doi.org/10.1186/1476-511X-13-173

Ejemplares similares